Liquid Biopsy Diagnostics Accurately Identify Pre-Cancer and Cancer Genes

An Empowered Patient Podcast at Medical and Pharma Insider hosted by Karen Jagoda


Richard Brand, Chief Financial Officer of DiaCarta discusses precision molecular diagnostics that are being used for early detection of cancer.


By using liquid biopsy technology, blood draw can be used for early detection and monitoring of people who have cancer and avoiding the need for a physical biopsy.


Also a radiation therapy and chemotherapy tests are supporting personalized medicine for those undergoing treatment who are at the extreme tails of the population - either very sensitive to it or have a very robust response - so as to better determine appropriate dosage.


Listen to Podcast


Transcription of Podcast